BRIEF published on 08/15/2024 at 15:12, 3 months 5 days ago Vanguard Group Discloses Position in Barratt Developments Form 8.3 Takeover Code Vanguard Group Shareholding Barratt Developments
PRESS RELEASE published on 08/15/2024 at 15:07, 3 months 5 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses 4.94% ownership in Barratt Developments plc as of 14 Aug 2024. Additional disclosures made for Redrow plc The Vanguard Group, Inc. Ownership Disclosure Financial Disclosure Redrow Plc Barratt Developments Plc
BRIEF published on 08/14/2024 at 15:08, 3 months 6 days ago Vanguard Group Discloses Position in Barratt Developments Securities Position Disclosure Takeover Code Vanguard Group Barratt Developments
PRESS RELEASE published on 08/14/2024 at 15:03, 3 months 6 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. disclosed a 4.94% stake in Barratt Developments plc as of 13 August 2024. Details of holdings and transactions provided The Vanguard Group Stake Disclosure Barratt Developments Plc Financial Holdings Transaction Details
BRIEF published on 08/13/2024 at 15:10, 3 months 7 days ago The Vanguard Group, Inc. Discloses Position in Barratt Developments plc Securities Disclosure Takeover Code Vanguard Group Barratt Developments
PRESS RELEASE published on 08/13/2024 at 15:05, 3 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. disclosed a 4.93% interest in Barratt Developments plc on 12 August 2024, alongside dealings details Disclosure The Vanguard Group Barratt Developments Plc Dealings Interests
BRIEF published on 08/12/2024 at 15:28, 3 months 8 days ago The Vanguard Group, Inc. Discloses Position in Barratt Developments plc Securities Disclosure Takeover Code Barratt Developments Vanguard
PRESS RELEASE published on 08/12/2024 at 15:23, 3 months 8 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses 4.93% stake in Barratt Developments plc as of 09 August 2024. Additional disclosure for Redrow plc Vanguard Group Financial Disclosure Stake Disclosure Redrow Plc Barratt Developments Plc
BRIEF published on 08/09/2024 at 15:50, 3 months 11 days ago The Vanguard Group Discloses Position in Barratt Developments plc Shares Disclosure Takeover Code Barratt Developments Vanguard
PRESS RELEASE published on 08/09/2024 at 15:45, 3 months 11 days ago Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc The Vanguard Group, Inc. discloses 4.93% stake in Barratt Developments plc. Open position disclosure made on 09-Aug-2024 The Vanguard Group Stake Disclosure Barratt Developments Plc Open Position 09-Aug-2024
Published on 11/21/2024 at 13:30, 16 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 16 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 46 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 46 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 46 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 11 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 31 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 48 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 26 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 1 minute ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 1 minute ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
